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Abstract
LINE-1 (L1) retroelements emerged in mammalian genomes over 80 million years ago with a few dominant subfamilies
amplifying over discrete time periods that led to distinct human and mouse L1 lineages. We evaluated the functional
conservation of L1 sequences by comparing retrotransposition rates of chimeric human-rodent L1 constructs to their
parental L1 counterparts. Although amino acid conservation varies from ,35% to 63% for the L1 ORF1p and ORF2p, most
human and mouse L1 sequences can be functionally exchanged. Replacing either ORF1 or ORF2 to create chimeric human-
mouse L1 elements did not adversely affect retrotransposition. The mouse ORF2p retains retrotransposition-competency to
support both Alu and L1 mobilization when any of the domain sequences we evaluated were substituted with human
counterparts. However, the substitution of portions of the mouse cys-domain into the human ORF2p reduces both L1
retrotransposition and Alu trans-mobilization by 200–1000 fold. The observed loss of ORF2p function is independent of the
endonuclease or reverse transcriptase activities of ORF2p and RNA interaction required for reverse transcription. In addition,
the loss of function is physically separate from the cysteine-rich motif sequence previously shown to be required for RNP
formation. Our data suggest an additional role of the less characterized carboxy-terminus of the L1 ORF2 protein by
demonstrating that this domain, in addition to mediating RNP interaction(s), provides an independent and required
function for the retroelement amplification process. Our experiments show a functional modularity of most of the LINE
sequences. However, divergent evolution of interactions within L1 has led to non-reciprocal incompatibilities between
human and mouse ORF2 cys-domain sequences.
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Introduction
The activity of LINE-1 (L1) elements has contributed both
directly and indirectly to almost a third of the human genome
mass [1]. Evidence of LINE retroelement activity dates as far back
as 100 million years ago (mya) [1–3]. L1 continues to be active in
the vast majority of mammalian species tested to date, with a few
exceptions [4,5]. Human and rodent lineages diverged approxi-
mately 80 million years ago, with each lineage harboring unique
L1 subfamilies [6,7]. Recent data demonstrate a significant con-
tribution of L1 activity to human genomic diversity [8,9] and
somatic variation in human lung cancer genomes [10]. Current
activity of L1 and its non-autonomous partners, Alu and SVA,
account for about 0.3% of new human germ-line diseases [11].
Estimates suggest that retrotransposition occurs at a rate of one in
21, 212, and 916 births for Alu, L1, and SVA, respectively [12].
Since the split between eutherians and marsupials, a single L1
clade continues to amplify with separate single dominant lineages
of L1 families in primates and rodents [13].
A full-length human L1 is about 6 kb, consisting of a 59
untranslated region (UTR), two open reading frames separated by
an intergenic sequence, and a 39 UTR which ends in a poly(A)
signal and an A-tail [14]. The two open reading frames, ORF1
and ORF2, code for activities necessary for L1 retrotransposi-
tion [15–17]. The general structure of these elements is relatively
conserved throughout L1 evolutionary history. However, the 59
UTR region containing the promoter sequence differs between L1
lineages of the same species [18,19] and between human and
rodent LINEs [20]. In addition, the ORF1 protein shows poor
sequence conservation between human and rodent L1 subfamilies,
particularly the amino terminus region (reviewed in [21]). The L1
ORF1 encodes a 40 kDa RNA binding protein which interacts
with the L1 transcript to form a ribonucleoprotein (RNP) particle
[22,23]. Studies indicate that ORF1p functions as a chaperone
[24] and is required for L1 retrotransposition [25]. The ORF2
encodes a 149 kDa protein with two known activities that can be
assigned to specific domains. The N-terminus contains an
endonuclease (endo) with sequence [17] and crystal structure
[26] similar to the APE-1 endonuclease, a component of the base
excision repair pathway. The reverse transcriptase (RT) activity is
found in the central domain of ORF2p, flanked upstream by
a conserved Z motif required for RT function [27]. Reverse
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reverse transcriptase inhibitors suppress retrotransposition [28,29].
The C-terminus or ‘‘cys-domain’’ contains a cysteine-rich motif
(CX3CX7HX4C) that is essential for L1 retrotransposition [16].
Mutations within the conserved motif abolish the ability of ORF2p
to interact with the L1 RNA [23]. However, the role of the rest of
the cys-domain remains unknown. Further details on the role of
the ORF2 protein are scarce due to the difficulty of its detection
and the limited availability of robust ORF2p antibodies [30,31].
Thus, researchers have used indirect methods to detect ORF2p
by measuring the effects of its enzymatic processes [32–34] and
developed alternate tools for its detection [23].
Comparison of the consensus sequences of the currently active
young human and mouse L1 elements reveals different lineage-
specific areas of amino acid conservation. In this manuscript, we
present data from an array of chimeric human-mouse L1 elements
and chimeric ORF2p that allowed us to determine species-specific
differences that influence retrotransposition. In addition, these
data provide insight into the less characterized cys-domain and
suggest an important functional role for a less conserved region of
the cys-domain that is distinct from the RNA binding function
of the highly conserved cysteine-rich motif.
Results
Human LINE-1 retrotransposition competence and RNA
primary sequence changes
LINE-1 elements from different species (human, mouse and
zebrafish) contain multiple premature polyadenylation signals and
splice donor and acceptor sites within their sequences [35–37],
leading to the generation of a diverse array of processed tran-
scripts. Because RNA processing and secondary structure could
possibly affect retrotransposition rate, we chose to minimize the
impact of the differences between the L1 sequences contributing to
effects on RNA levels by working with codon optimized human
and mouse coding sequences driven by the CMV promoter (see
methods). Thus, our approach should largely confine any species-
specific observations to the amino acid sequences of the human
and mouse L1 elements. Moreover, past studies utilizing synthetic
codon optimized L1 constructs improved transcription of the full
length retrocompetent L1 transcripts, increased protein expression
and augmented retrotransposition rates in ex vivo assays [33,38,39].
These observations suggest that the RNA largely plays a passive
role within the L1 RNP as a retrotransposition intermediate. Our
codon optimized version of a minimal L1RP (pBS-L1PA1CHmneo,
Figure 1) is consistent with these observations. We find that
optimization reduces some of the processing of the full length L1
RNA and that our tagged minimal human L1 construct generates
about twice as much full length L1 mRNA compared to the wild-
type L1.3 element (transcripts with the spliced or unspliced neo
tag) (Figure 1B). The highly expressed low molecular weight band
observed for L1.3 in Figure 1B likely represents common splice
transcript variants that exclude most or all of the L1 coding se-
quences previously shown to be generated by L1 elements [36].
Transient transfection assays reveal that the optimized minimal L1
also retrotransposes with high efficiency compared to wild-type L1
(Figure 1C).
Human and mouse ORF1 and ORF2 are interchangeable
The human and rodent L1 lineages have evolved independently
for approximately 80 million years. The ORF1p and ORF2p of
the currently active human and mouse elements share approxi-
mately 35% and 63% amino acid identity, respectively. To test for
a species-specific interaction between L1 ORF1–ORF2 proteins,
we individually substituted the ORF1 or ORF2 sequences of a
tagged mouse (psmL1) and human (L1PA1) L1 construct with the
same ORF from the opposite species and used these chimeric
L1 elements in the retrotransposition assay. All of the chimeric
ORF1–ORF2 L1 constructs maintain retrocompetence (Figure 2);
however, the chimeric L1 retrotransposition rates were lower than
the parental counterparts, ranging between 60–69.5% activity
relative to the parental elements.
Generation of human-mouse ORF2 chimera
We generated 12 human-mouse ORF2 chimeric proteins by
swapping homologous sequences between species and selected
sequence breakpoints to preserve distinct functional domains
(Figure 3A). We subdivided the multifunctional L1 ORF2 protein
Figure 1. Codon optimized minimal human L1 is retrocompe-
tent. A. Schematic of the optimized human L1 construct. The CMV
promoter drives the transcription of the fully optimized ORF1 and ORF2
for L1RP. The L1 vector is tagged with the mneoI indicator cassette
containing an inverted neomycin resistance gene. The SV40 promoter
(SV40p) drives transcription of the neomycin gene which is disrupted by
an intron in the opposite orientation that renders it non-functional [16].
The intron is only spliced out from tagged L1 transcripts generated by
the CMV promoter. When retrotransposition of the spliced L1 RNA
occurs, the new insert will contain a functional neo gene that is
expressed from the SV40 promoter. Only retrotransposed copies of the
spliced RNA will confer G418 resistance. Some of the unique restriction
sites used in the construction of the other vectors are shown.
B. Northern blot analysis of the RNA profiles, 48 hours post-
transfection, of transiently transfected HeLa cells with the tagged ‘‘wild
type’’ L1.3 construct JM101/L1.3 (L1.3) and the tagged optimized
minimal human L1PA1CHmneo (PA1) using a probe to the 39 region of
the neomycin gene. The full-length unspliced tagged L1 transcript
(arrow) and the transcript with spliced neo tag (open arrowhead) are
indicated. The inset shows the cyclophilin transcript (asterisk). The
spliced (Sp) full length L1transcript and the total (spliced and unspliced;
Tot) full length L1 RNA were normalized to cyclophilin and calculated
relative to the L1.3 construct (designated as 1.0). The mean 6 the
standard deviation for the quantitation results for each construct is
indicated below (n=2). The highly expressed low molecular weight
band observed for L1.3 likely represents common splice transcript
variants that exclude most or all of the L1 coding sequences previously
shown to be produced by L1 elements [36]. C. The retrotransposition
capability of L1PA1CH and L1.3 was assayed in HeLa cells. The optimized
minimal human L1 is retrotransposition competent.
doi:10.1371/journal.pone.0019672.g001
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the reverse transcriptase (RT) plus the Z-motif, and the carboxy-
terminus domain containing the cysteine-rich motif (cys). The cys
domain was further subdivided into three stretches of roughly
equal size. The chimera breakpoints with their relation to the
ORF2 domains and the 12 chimeras are detailed in Figure 3A.
The endonuclease containing region is well characterized with a
clearly defined self-sufficient domain [26,40]. We defined the RT
domain region as the sequence starting immediately 39 of the EN
domain, including the required Z-motif, and terminating with the
RT domain as recognized by the conserved domain database
(cdd pfam00078.12) from NCBI [41]. We refer to the remaining
carboxy-terminus ORF2p residues, including the cys-motif at
residues 1129–1147, as the ‘‘cys domain.’’ Because the function of
the cys domain is largely unknown, we further subdivided this
region into three segments of roughly equal size for more detailed
analysis, with the carboxy-terminal segment containing the con-
served cys-motif.
Chimera breakpoints were introduced in areas of conserved
amino acid sequence ranging from 3–9 identical residues sur-
rounding the breakpoints (Figure 3B). The protein alignment is
unambiguous with only a single seven residue insertion/deletion
difference between human and mouse ORF2p at the beginning
of the endo domain. Thus, the breakpoints within the ORF2 of
each species are certain to be at identical positions. Complete
alignments of the ORF2p from several mammalian species, in-
cluding human and mouse, demonstrate high conservation of the
amino acid sequence at the site of the breakpoints (Figure S1).
Amino acid conservation of the individual ORF2p sections varies
(Figure 3B). There is clearly some heterogeneity of divergence,
where the endo region (56.6%) and the middle cys 2 region
(51.5%) show lower amino acid identity than the complete protein
(62.9%).
The mouse and human ORF2 endonuclease and reverse
transcriptase domains are interchangeable
We evaluated the functionality of the chimeric ORF2 proteins
by assessing their ability to support Alu retrotransposition in trans
in the human HeLa cell line. Because ORF2p alone is sufficient
to drive Alu retrotransposition in the assay [42], we did not use
ORF1 in any of the Alu retrotransposition experiments. This
approach simplified the interpretation of our ORF2 chimera
results, since an additional complicating variable (human or mouse
ORF1) was not required to assess functionality. The four reci-
procal chimeras with swapped endonuclease (mouse with human
endo: HMM; and human with mouse endo: MHH) and RT
domains (mouse with human RT: MHM; and human with mouse
RT: HMH) were all functional, with only MHM showing more
than a 35% drop in retrocompetence (30.9% activity relative to
mouse: MMM) (Figure 3A).
Sequences from the cys-domain of mouse ORF2 are
incompatible with the human protein
Inefficient support of Alu retrotransposition in
trans. The mouse ORF2p is functional when any portion of
its cys domain is substituted with human counterparts (Figure 3A:
mouse with the human cys: MMH and MMmhh, and MMmmh).
The same is not true for the human ORF2 protein. The only
human chimera with a portion of the mouse cys domain that
effectively supported Alu retrotransposition in trans was HHhhm
(Figure 3A). The other ORF2 construct variants with different
portions of the mouse cys sequences in the human ORF2p (HHM,
HHhmm, and HHhmh) did not support Alu retrotransposition.
Transfections with HHhmm and HHhmh chimeras produced
significantly fewer colonies than the negative empty vector control
(two-tailed, two sample T-test, p,0.01) and HHM transfections
showed a similar trend but were not significantly different than
empty vector. We therefore considered that the colonies from
these three sets of transfections likely represent background co-
lonies derived from endogenous L1 proteins in HeLa cells [43]
and that the means below background level indicate either
a dominant negative effect or toxicity associated with ORF2
transfections [44,45]. Even if these chimera function at a
very low efficiency (i.e., ,1000 fold reduction), a decrease in
retrotransposition rate of this magnitude compares to that ob-
served for the endonuclease and reverse transcriptase mutant L1
constructs, which are considered to be essentially ‘‘non-functional’’
[16]. Transfection of these constructs in the mouse NIH3T3 cell
line yielded comparable results (Figure S2) with proportio-
nally fewer overall colonies. It is not surprising to observe lower
numbers as retrotransposition assay efficiency varies across cell
lines and even between different laboratory stocks of the same cell
line [46]. The three ORF2 chimeras (HHM, HHhmm, and
HHhmh) were unable to support Alu retrotransposition (i.e., not
significantly different from the empty vector control; two sam-
ple T-test, p$0.238) irrespective of the cell line utilized, while
HHhhm was not significantly different from the single species
ORF2p positive control (two sample T-test, p=0.21).
Inefficient support of L1 retrotransposition. We selected
two of the ‘‘non-functional’’ ORF2p chimera (HHM and
HHhmh) for evaluation in the context of our tagged human L1
construct. As with trans-mobilization of Alu, we observed between
one and two L1 colonies per experiment (Figure 3C), suggesting
Figure 2. Mouse and Human ORF1 and ORF2 are interchange-
able. Retrotransposition assay results of tagged mouse (psmL1),
human (pBS-L1PA1CHmneo), and chimeric ORF1–2 L1 constructs.
Human-mouse ORF1–2 chimeras were made from the parental
constructs of both species by replacing either the ORF1 or ORF2 with
the equivalent ORF from the other species. Each set of three flasks
shows the parental single species (left), chimeras with swapped ORF1
(middle), and chimeras with swapped ORF2 (right). Average number of
colonies and standard deviation from two replicate experiments is
shown for each construct.
aPercent activity relative to the parental is
indicated for each of the chimeras.
doi:10.1371/journal.pone.0019672.g002
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19672Figure 3. L1 ORF2p human-mouse chimera. A. Chimera breakpoint schematic of chimeric ORF2s and their ability to drive Alu
retrotransposition in trans. A schematic for the L1 ORF2 protein with its three recognized domains, endonuclease (endo), reverse transcriptase
(RT) and the ill-defined 39 region containing the cysteine-rich motif (cys), subdivided into three parts. The amino acid positions flanking the selected
break points are indicated for human and mouse ORF2s. The constructs are named using 3 capital letters, each representing a domain: H for human
and M for the mouse portions, where HHH and MMM represent complete human and mouse ORF2 proteins, respectively. In constructs where the cys-
domain was further subdivided, the third capital H or M was replaced with three lowercase h or m letters, indicating the subdivision of the cys-
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supporting L1 retrotransposition in cis. The introduction of these
cys-domain mouse sequences into the ORF2p of the human L1
element reduces retrotransposition by 200–350 fold.
Evaluating expression and protein functions of the ORF2
human-mouse chimera. Inefficient expression could explain
the reduced retrotransposition activity observed for the ORF2
chimeric protein. We assessed protein expression using western
blot analysis of extracts from cells transfected with all the chimeric
ORF2 constructs. A band with an apparent molecular weight
(,150 kDa) corresponding to ORF2p was detected for human
and chimeric ORF2p transfections (Figure 4A). These results
suggest that all of the ORF2 chimera constructs are capable of
generating stable levels of protein.
The lack of the actual structure of the complete ORF2 protein
limits the predictions on how changes in the cys-domain of these
chimeric ORF2 proteins may affect the endonuclease or reverse
transcriptase activities. Therefore, we proceeded to assess whether
the presence of mouse cys-domain sequences in the human
ORF2p might affect the two known activities of the protein. We
evaluated the endonuclease activity of the chimeric ORF2 proteins
showing poor retrotransposition capability using the alkaline
COMET assay that detects both single strand nicks and double
strand breaks introduced in DNA. All of the tested ORF2p
chimera generated a significantly higher number of DNA nicks/
breaks (Student paired T-test, p#0.005) compared to the empty
vector and the EN
2RT
2 ORF2p control (Figure 4B). We next
assessed reverse transcriptase activity using the previously
described LEAP assay that was developed for L1 [47] and shown
to be useful for detecting activity from cell extracts transfected with
constructs that express ORF2p alone [23]. This assay detects
ORF2p-RNA (RNP) complexes by evaluating the ability of
ORF2p to reverse transcribe the RNA in vitro (detailed in
Figure 4C). Following the published protocol, we utilized the
two described linker oligos to generate the cDNA. One contains a
poly-adenine stretch at the 39 end, referred to as ‘‘no anchor
(NA),’’ and the other contains a poly-adenine stretch that ends
with an anchor (NV; see Figure 4C). Our results indicate that the
retrotransposition-deficient ORF2p chimera maintain an active
reverse transcriptase that can still interact effectively with its RNA
(Figure 4C). Overall, these data indicate that the inactivity of the
HHhmm, HHM and HHhmh ORF2p chimera appear to be due
to an undetermined but critical function of the cys-domain.
Discussion
L1 elements have been replicating and evolving in mammals for
approximately 100 million years. Because a retroelement is
generally parasitic upon its host genome, the potential for
parasite-host coevolution may have contributed to some indepen-
dent evolution of L1 sequences and host factors in different
lineages. The basic organizational structure of L1 is the same for
all mammalian elements, consisting of the 59UTR-ORF1–ORF2-
39UTR and poly(A). Previous in vivo work demonstrated that the
L1 59UTR can be completely removed and replaced by another
unrelated promoter, such as the composite CMV enhancer
modified chicken b-actin promoter [48]. In addition, the complete
removal of the 39UTR sequence still allows for L1 retrotranspo-
sition. Although the 39UTR contains a conserved G-rich motif (G)
[49], data suggest that the 39UTR is not essential for the
retrotransposition process but may instead provide a supportive
role. Codon optimization of L1 sequences could alter L1 RNA
folding and affect its interaction with ORF1 or ORF2. However,
as previously observed for the mouse L1spa [38] and human L1RP
[33,39], these changes do not negatively impact L1 activity. Our
minimal optimized L1 is retrotranspositionally more efficient than
the wild type tagged L1.3. Several factors likely contribute to this
result, including a higher inherent L1RP retrotransposition rate
relative to L1.3, an increased amount of the full length L1
transcript, and possibly an increase in translation efficiency due to
the codon optimization of the construct.
The modularity of L1 sequences becomes more evident with
our observation that chimeric L1 human-mouse ORF1–ORF2
constructs maintain retrotransposition competence. Of particular
interest, the ORF1 sequence was subjected to intense positive
selection during a brief period of primate evolution, resulting in a
high rate of amino acid replacement in the coiled-coil domain,
which is currently conserved in the human ORF1p [50]. The same
ORF1 region in rodent L1 lineages also experienced a high rate of
amino acid replacement [3,51–53]. The coiled-coil domain
mediates ORF1p multimerization and it has been suggested that
it may also promote interaction with other proteins, possibly
ORF2p [54,55]. Recent data demonstrate that mutations in
the putative leucine zipper or RRM of ORF1p lead to reduced
amounts of ORF2p in L1 RNP containing fractions [23].
However, our data suggest that although there might be important
species-specific epistatic interactions between ORF1p and ORF2p,
these inter-protein interactions are not sufficient to abolish the
retrotransposition competence of our chimeric constructs.
The ability of chimeric human-mouse ORF2 proteins to mo-
bilize Alu in trans was independent of the species (mouse or human)
of the transfected cell line. We previously demonstrated that
ORF2p from both mouse and human L1 sources mobilizes tagged
Alu transcripts in chicken cells [56]. Our observations suggest that
the potential interaction of ORF2p chimera with species-specific
host factors is not required in our experimental assays. Amino acid
comparison of the human and mouse ORF2 proteins identifies
two regions with decreased conservation relative to the complete
domain. HeLa cells were co-transfected with a tagged Alu and the different chimeric ORF2 expression constructs. Results from the Alu
retrotransposition assay average colony counts with standard deviation, along with images of representative colony assays, are shown to the right of
each of the construct schematics. Averages are derived from six replicate experiments. Assay results using an empty vector (i.e., no ORF2 supplied in
trans) show the average number of background colonies of Alu retrotransposition events that are inferred to be derived from endogenously
expressed ORF2p in human HeLa cells. An asterisk (*) represents significant difference from empty vector, p,0.01, two-tailed two sample T-test; $
represents not significantly different from empty vector. B. Chimera breakpoints and amino acid conservation between human and mouse
L1 ORF2 proteins. ORF2p chimera breakpoints and numbers of amino acids (aa, taken from the human ORF2p) are shown in the first row. The next
two rows show the five amino acid residues on each side of the breakpoints (ORF2s from human L1RP and mouse L1spa). Conserved human and
mouse residues are highlighted. The three bottom rows show average amino acid conservation between human and mouse proteins for the
indicated ORF2p segments. The location of the cys-motif is shown at the top as a dark bar. C. Tagged LI constructs with substituted chimeric
ORF2p HHM and HHhmh in place of the parental ORF2 significantly limit L1 cis retrotransposition capability. L1 retrotransposition
assay results in HeLa cells using the parental human L1 construct (pBS-L1PA1CHmneo, shown as L1-HHH) and the same construct with substituted
chimeric ORF2, as indicated. The observed G418
R foci (mean 6 standard deviation) are indicated for three repeats of the experiment, with the L1
chimeras showing significantly fewer colonies than the parental L1 (200–350 fold difference; p,0.0001, one-tailed two sample T-test).
A representative of the retrotransposition results is shown with arrows indicating infrequent colonies from the chimeric L1 transfections.
doi:10.1371/journal.pone.0019672.g003
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56.6% identity and the middle subsection of the cys-domain with
51.5% identity (Figure 3B, details in Figure S3). Unlike the cys-
domain, the endonuclease domain was easily exchanged between
the two species. We anticipated the endonuclease modularity, as a
similar approach demonstrated the interchangeability of endonu-
clease domains for the non-LTR elements SART1 and TRAS1
[57]. In addition, previous in vitro work demonstrated that this
domain maintains endonuclease activity independent of the rest of
the ORF2 protein [17,58]. The reverse transcriptase domain also
proved to be interchangeable. The RT domain contains ten highly
conserved regions that are shared amongst most non-LTR
retrotransposons [59]. This high conzservation probably reflects
functional constraints on the reverse transcriptase and is consistent
with our observation that mouse and human RT sequences are
interchangeable.
The simplest interpretation of our data is that predominantly
human ORF2 protein is incompatible with the middle subsection
of the mouse cys domain. All three of our chimeras that fit this
description were essentially non-functional, while reciprocal mouse
ORF2 chimeras maintained retrotransposition competence. Func-
tionality of these chimeras could not be rescued by the use of cells
from either species or by the addition of ORF1p in the context of
the bicistronic L1 constructs. Given the important role that the
cys-domain appears to play in functionality, it is notable that the
highly conserved cys-motif is not associated with the observed
species-specific difference. Reciprocal chimeras that only affected
the third subsection of the cys-domain containing the conserved
cys-motif (HHhhm and MMmmh) were both highly functional.
The inhibitory effect caused by one or more sequence stretches
of the mouse cys-domain in the context of the human pro-
tein appears to be independent of the endonuclease or reverse
transcriptase activities of ORF2p, as demonstrated by our func-
tionality assays. Previous work demonstrated that substitutions of
the cysteines in the cysteine rich motif lowered the amount
of ORF2p in the RNP fraction and reduced LEAP activity,
suggesting a possible reduction in the ORF2p-RNA interaction
[23]. In contrast, our retro-incompetent ORF2p cys-domain chi-
mera (HHhmm, HHM and HHhmh) show no reduction in the
LEAP assay. Our observations reinforce separate roles for the cys-
motif and the middle section of the cys-domain. However, it
remains possible that the exchanged region has an interface
with the endonuclease and/or RT domain in the retroincompe-
tent ORF2p chimera. Our data show that retrocompetence can
be recovered from the non-functional HHM by swapping the
human endonuclease domain for the mouse (i.e., HHMRMHM).
However, the MHM ORF2 is only ,30% active relative to the
Figure 4. Evaluation of chimeric ORF2p expression and
functionality. A. Detection of ORF2 protein. Western blot analysis
of extracts from transiently transfected HeLa cells with constructs
expressing the following human-mouse ORF2 chimeric proteins: 1-
MMmhh, 2- HHhmm, 3- HHM, 4- MMH, 5- HHhmh, 6- HHmhh, and 7-
optimized human ORF2 (HHH). An arrow indicates the expected
position of the 149 kDa ORF2 protein. B. Evaluation of endonucle-
ase activity. Alkaline comet assay for the detection of DNA breaks of
transiently transfected cells plasmids expressing the optimized human
ORF2 (HHH), an endonuclease and reverse transcriptase mutant
(EN
2RT
2), and the three chimera that are incapable of inducing
retrotransposition above background levels (HHM, HHhmm, and
HHhmh). The experiment is one representative of three repetitions.
Results from Student paired T-test relative to the empty plasmid control
(vector) are indicated. Significant differences were observed for all ORF2
constructs, except for the RT
2 and EN
2 ORF2 mutant (negative control).
Note that all cells are exposed for the gamma-irradiated control (IR),
while only a portion of the cells transfected with the ORF2 constructs
express the ORF2 protein of interest due to the transfection efficiency.
C. Schematic of the LEAP assay. The LEAP assay was previously
developed for the detection of L1 ribonucleoprotein (RNP) complexes
containing ORF2p and an RNA template [47]. The assay consists of a
partial purification of a cytoplasmic subcellular fraction containing
ORF2p and L1 RNA as part of the L1 RNP. Isolated RNPs, along with
nucleotides and a linker oligo (to function as the priming site), were
used for in vitro detection of the reverse transcriptase activity of the L1
ORF2p [23]. Two types of linkers are used: one with ‘‘no anchor’’ having
only thymidine residues at the 39 end (NA; not shown) and one with
two residues to function as an anchor at the 39 end (NV; shown). The
generated cDNA is detected by PCR amplification using a primer
complementary to the cDNA and to the sequence of the linker oligo.
D. Evaluation of reverse transcriptase activity. Reverse transcrip-
tase activity of the different ORF2 chimera was assessed with the LEAP
assay using primers to detect cDNA generated from the ORF2
transcript. Extracts from HeLa cells transfected with the different
ORF2 chimeric constructs were assayed using the linker with no anchor
(NA) or the linker with anchor (NV). No linker oligo was added to the
negative control (2). The empty plasmid (vector) and the RT
2 and EN
2
ORF2 mutant were used as negative controls. The arrow indicates the
expected size product for a positive result.
doi:10.1371/journal.pone.0019672.g004
Conserved L1 Functional Modularity
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19672parental HHH or MMM constructs. We observe a higher
recovery effect with the RT domain, as functionality is also
restored when the non-functional HHM is compared to the
functional HMM construct with ,66% activity of HHH or
MMM. Because activity is not fully restored in either of the two
chimeric proteins, it is possible that the decrease in retro-
competence is due to negative sequence interactions and/or in-
efficient structural folding of the ORF2 protein.
Interestingly, the smallest tested sequence with negative impact
(165 aa of the middle sub-section of the cys-domain) is also the
one with the lowest amino acid identity (Figure 3B), which could
possibly indicate a region that has evolved in response to inter-
actions with other L1 sequences or host factors. Without more
detailed knowledge of the structure and function of the cys-domain
of ORF2p, any interpretations at this time are limited. Our data
show that a region of the cys-domain has evolved to lose some of
the modularity that is preserved by the other ORF2 domains.
Phylogenetic analysis of the timeframe of cys-domain evolution
could show whether or not it is correlated with amino acid changes
in other L1 coding regions and provide insight into the nature of
the sequence and/or protein interactions that influence chimera
functionality.
Materials and Methods
Constructs
pBS-L1PA1CHmneo, contains the fully codon optimized ORF1
and ORF2 of the human L1RP cloned in the pBluescriptII vector
(Stratagene). A schematic of the synthetic L1 vector is shown in
Figure 1A. The L1 open reading frames were codon optimized
using Primo Optimum 3.4 (http://www.changbioscience.com/
primo/primoo.html), which makes synonymous changes to
optimal codons within the nucleotide sequence. A 63 bp inter-
ORF with 92% sequence identity to L1RP was utilized for all
constructs. Sequence changes to this region were generated to
introduce restriction enzyme sites used for plasmid construction.
The optimized nucleotide sequence is 74.9% identical to the
sequence of L1RP. The ‘‘notag’’ constructs contain an SV40
polyadenylation signal at the 39 end, and the others contain the
mneoI cassette including the SV40 polyadenylation signal from
JM101/L1.3 [60].
pBS-L1PA1CHrescue, contains the L1RP ColE1-mneo cassette of
SynL1neo [61] instead of the mneoI cassette. The ColE1-mneo
cassette was amplified with the FseI-NeoTag: 59-TCCTAGC-
TGGCCGGCCTTTTATTGCCGATCCCCT-39 and Not-Neo-
Tag: 59 –TCCTAGCTGCGGCCGCAACGCGCGAGGCAGC-
CGGATCATA-39 and cloned into the FseI and NotI sites of pBS-
L1PA1CHmneo (Figure 1).
pBudORF2 human-mouse chimera were generated by a PCR
approach using overlapping primers [62] using pBudORF2opt
[33] and psmL1‘‘ORFeus’’ derived from L1spa (a kind gift from
Dr. Jef Boeke) [38] as source sequences. ORF2opt codes for the
L1RP ORF2 protein sequence and was codon optimized by Blue
Heron Biotechnology, Inc (Bothell, WA). The open reading frames
are cloned into the expression vector pBudCE4.1 (Invitrogen),
under control of the CMV promoter. The nomenclature and
break points of the chimeric ORF2 constructs are described in
Figure 3A.
pBS-L1-1H,2Mmneo and pBS-L1-1M,2Hmneo were derived
from pBS-L1PA1CHmneo and contain either the mouse ORF1 or
ORF2 of psmL1 [38] as source DNA.
pCEP-L1synM-1H and pCEP-L1synM-2H contain the codon
optimized human ORF1 or ORF2 (L1RP) in psmL1 [38].
pBS-L1-1H,2HHM mneo, and pBS-L1-1H,2HHhmh mneo were
derived from pBS-L1PA1CHmneo and contain the indicated
human-mouse chimeric ORF2 as shown in Figure 3A.
JM101/L1.3, referred to as ‘‘wildtype’’ L1, contains a full-
length copy of the L1.3 element and the mneoI indicator cassette
cloned in pCEP4 (Invitrogen) [60,63].
All plasmid DNA was purified by alkaline lysis and twice
purified by cesium chloride buoyant density centrifugation and
quality assessed by the visualization of agarose gel electropho-
resed aliquots stained with ethidium bromide. Constructs were
confirmed by sequencing (Elim Biopharmaceuticals Inc, Hay-
ward,CA).
L1 and Alu retrotransposition Assays
Transient L1 or Alu retrotransposition assays were performed
as previously described with some minor modifications [34].
Briefly, HeLa (ATCC CCL2) or NIH3T3 (ATCC CRL1658)
cells were seeded at a density of 5610
5/T75 flask or 2.5610
5
cells/T25 flask. Transient transfections were performed the fol-
lowing day with Lipofectamine Plus (Invitrogen) following the
manufacturer’s protocol using 1 mgo fA l u - neo
TET vector plus
0.33 mg of the ORF2 construct or empty vector (T25 flask). For
L1 retrotransposition assays between 1 or 3 mg of the tagged L1
plasmids was used for transfection (T75 flask). The next day, the
cells were treated with the appropriate media containing 400 mg/
ml for HeLa and 800 mg/ml for NIH3T3 cells of Geneticin/
G418 (Fisher Scientific). After 14 days, cells were fixed and
stained for at least 30 minutes with crystal violet (0.2% crystal
violet in 5% acetic acid and 2.5% isopropanol). Retrotranspo-
sition rate was then determined as the number of visible G418
R-
resistant colonies/10
6 cells seeded. Both L1 and Alu G418
resistant colonies were validated as authentic retrotransposition
events (Figure S4).
Northern blot analysis
HeLa cells were seeded at a density of 4610
6 for transfection
with 5 mg of the L1 plasmid constructs. Cells were harvested
48 hours post-transfection for RNA extraction. RNA extraction
and poly(A) selection was performed as previously described [35].
The polyadenylated transcripts were electrophoresed in a 1%
agarose-formaldehyde gel and then transferred to a Hybond-N
nylon membrane (Amersham Biosciences). The RNA was UV
cross-linked to the membrane using a UV-light (GS Gene linker,
BioRad). The membrane was pre-incubated in hybridization
solution: 30% formamide, 16Denhardt’s solution, 1% SDS, 1 M
NaCl, 100 mg/ml salmon sperm DNA, 100 mg/ml yeast t-RNA
at 60uC for at least 3 hr. A riboprobe to the 39 region of the
neomycin gene was generated using a PCR product amplified
with the following primers T7neo(2): 59-TAATACGACTCAC-
TATAAGGACGAGGCAGCG-39 and Neo northern(+): 50-G A -
AGAACTCGTCAAGAAGG-39. The cyclophilin riboprobe was
generated from pTRI-cyclophilin template (Ambion) to use as a
control for transcript quantitation analyses. Riboprobes were
radioactively labeled by incorporating
32P-UTP (Amersham
Biosciences) using the MAXIscript T7 kit (Ambion) following
the manufacturer’s recommended protocol. The radiolabeled
probes were purified by filtration through NucAway Spin
columns (Ambion). Separate hybridizations were performed
overnight with 4–12610
6 cpm/ml of each individual probe at
60uC. The membrane was washed twice at high stringency (0.16
SSC, 0.1%SDS) at 60uC before analysis using a Typhoon Pho-
sphorimager (Amersham Biosciences) and the ImageQuant
software.
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Protein was extracted from trypsinized and PBS-washed
transiently transfected NIH3T3 or HeLa cells using standard
Tris SDS glycerol buffer plus 2-mercaptoethanol and boiled for
15 min. Extracts were electrophoresed on 4–12% NuPage Bis-Tris
gels (Invitrogen). Proteins were transferred to a nitrocellulose
membrane using the iBlot gel transfer system (Invitrogen). The
goat anti-LINE (S-19, an affinity purified goat polyclonal antibody
raised against a peptide mapping near the ORF2 N-terminus of
human LINE-1) and secondary HRP-conjugated antibodies were
purchased from Santa Cruz Biotechnology Inc. The membrane
was incubated for 1 h at room temperature with the primary or
secondary antibody diluted 1:500 and 1:5000 in PBS pH 7.4 plus
0.05% Tween 20 and 3% non-fat dry milk (Biorad), respectively.
Signals were detected using the SuperSignalWest Pico Chemilu-
minescent Substrate (Pierce, Rockford, IL) and Amersham ECL
hyperfilm (GE Healthcare).
Comet assay
HeLa cells were transfected with 1 mg of plasmid expressing the
different ORF2 expression plasmids and controls. After 24 hours,
cells were harvested and gently resuspended in phosphate buffer
saline (PBS pH 7.4) to a concentration of 10
5 cells/ml. Gamma-
irradiated (5 Gy) cells were used as positive control, untreated cells
as background and the empty vector plus an endonuclease and
reverse transcriptase ORF2 mutant as negative controls. The
alkaline comet assay was performed by using the CometAssay
Reagent Kit for Single Cell Gel Electrophoresis (Trevigen,
Gaithersburg, MD) following the manufacturer’s instructions.
Cells were mixed with low melting agarose (Comet LMAgarose,
Trevigen) and embedded on a slide (CometSlide, Trevigen). Slides
were incubated in cold lysis solution (Trevigen) for 45 minutes
at 4uC. Slides were then incubated in Alkaline Solution, pH.13
(300 mM NaOH, 1 mM EDTA) for 40 minutes at room
temperature in the dark. Cells were then electrophoresed in
Alkaline Electrophoresis Solution, pH.13 (300 mM NaOH,
1 mM EDTA) in a horizontal gel apparatus (Bio-Rad, Hercules,
CA) at 1 V/cm for 30 minutes at 4uC. Slides were rinsed briefly in
dH2O and then incubated in 70% ethanol for 5 minutes. Slides
were air-dried overnight and DNA stained with SYBR Green I
(Trevigen). Cells were analyzed using an epifluorescence micro-
scope (Nikon, Melville, NY). Digital images were acquired with a
SensiCam QE digital camera (Cooke Corporation, Romulus, MI).
Tail moments were determined for at least 75 random cells per
sample by using Comet Assay IV (Perceptive Instruments, United
Kingdom) comet scoring software. Tail moment is defined as the
ratio of DNA in the comet tail to total DNA.
ORF2 LEAP assay
HeLa cells (4610
6/T75 flask) were transfected with 10 mg of the
ORF2-expressing constructs. Cells from two transfected flasks
were pooled and harvested 48 h post-transfection following the
previously described protocol [47]. The LEAP reaction product
was generated using the published linkers, LEAP NV: 59-G-
AGCACAGAATTAATACGACTCACTATAGGTTTTTTTT-
TTTTVN-39 and LEAP NA: 59-GCGAGCACAGAATTAATA-
CGACTCACTATAGGTTTTTTTTTTTT-39. No LEAP prim-
er was added to the negative control. The LEAP cDNA product
was PCR amplified using the anchor primer (59- GCGAGC-
ACAGAATTAATACGACT-39) and a primer specific to a se-
quence shared by both the mouse and human ORF2p constructs
near the 39end of the gene (ORF2-39B: 59-ACGGATCCGAAC-
AAAAACTCATC-39). A 3 ml aliquot of the LEAP product was
PCR amplified for 35 cycles of 20 s at 94uC, 30 s at 62uC and
30 s at 72uC, with a final cycle of 5 min at 72uC and visualized on
a 2.5% agarose gel.
Supporting Information
Figure S1 Amino acid conservation between mammali-
an L1 ORF2 proteins. We used the Clustal W algorithm of the
MegAlign alignment program (LaserGene; DNAstar) to align
ORF2 protein sequences from human (L1RP), mouse (L1spa), rat,
dog, rabbit, cow, tree shrew, and horse. Sequences other than
human and mouse were collected from the Repbase Update
database [1]. The consensus is shown at the top; amino acid
residues shaded gray are identical to the human ORF2 sequence.
The four breakpoints used in chimera construction follow position
numbers 268, 795, 957, and 1123 from this specific alignment.
(TIF)
Figure S2 The human and mouse chimeric HHM,
HHhmm, and HHhmh chimeric L1 ORF2ps are unable
to support Alu retrotransposition in a rodent cell line.
NIH3T3 (mouse) cell line was transiently transfected with the
three ORF2p chimeric proteins that were non-functional in HeLa
and a tagged Alu vector. All three constructs (HHM, HHhmm,
and HHhmh) generated Alu colonies at a rate that was not
significantly different than the empty vector control. The results
in rodent cells NIH3T3 emulate the results obtained in the
human HeLa cells, the other cys-domain mutant (HHhhm)
was functional. The functionality of these ORF2 human-mouse
chimera appears to be independent of cell line species (mouse or
human). Two sample T-test analysis showed: * Significantly
different than HHM, HHM2, HHhmh, and empty vector
p,0.01; $ Not significantly different than empty vector
p$0.238; # not significantly different than MMM p=0.210.
(TIF)
Figure S3 Amino acid alignment between the non-
exchangeable region of the L1 ORF2 cys domain of
mouse and human shows low and dispersed amino acid
identity. The region encompassing 160 amino acids of the mid-
section of the cys domain of the L1 ORF2p is shown. The
consensus is shown at the top; identical amino acids are shown and
non-identical amino are shaded in gray.
(TIF)
Figure S4 The L1 and Alu inserts recovered present the
features of bona fide retrotransposed elements. L1 and
Alu G418
R colonies were selected and grown to confluency. DNA
was extracted from the cells using the DNA Easy kit (Qiagen)
following the manufacturer’s recommended protocol. A. L1 in-
serts were recovered and analyzed using a previously published
method [2]. The representation of two examples of recovered
inserts generated by L1PA1CH tagged with the mneoI/ColE1
cassette [3] is shown. Both examples shown are 59 truncated L1
sequences (3088 bp and 3099 bp excluding the Atail). The tagged
L1 sequence is represented as ‘‘L1+ColE1-mneo cassette’’ high-
lighted in gray. The tandem site duplications are underlined.
The canonical polyadenylation signal is underlined and shown
in italics. B. The extracted DNA from cells transfected with the
tagged Alu vector plus the different ORF2 expression constructs
was evaluated by performing nested PCR with primers designed
to amplify the sequences flanking the self splicing intron, F1: 59-
GGGCGCCTGTAGTCCCAGCTA -39; F2: 59-TAGCAGCCA-
GTCCCTTCCCGCTTCA-39; R1: 59-GTCAGCGCAGGGG-
CGCCCGGTTC-39 and R2: 59-ACTGGGCACAACAGACAA-
TCGGC-39 ). The annealing location of the primers are shown in
the schematic of the Alu construct. An open arrowhead indicates
Conserved L1 Functional Modularity
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version (open arrowhead) of the Alu expression vector. An open
arrowhead indicates the nested 217 bp PCR product correspond-
ing to an insert containing the spliced version (open arrowhead) of
the Alu expression vector. Lanes correspond to the following
chimeric ORF2 constructs: 1- MMmhh, 2- MMH, 3-HHmhh, 4-
HHhhm, 5- MMmmh, 6- HMM, 7- MHH, 8- MHM, and 9-
HMH. M denotes the DNA, and the Alu expression plasmid
(P lane) was used as the control for 625 bp unspliced product
(black arrow).
(TIF)
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